Search results for " DEMENTIA"

showing 10 items of 165 documents

Frequency and caregiver’s burden of frontotemporal dementia in ALS patients and their caregivers

ALS Frontotemporal dementia burden of careALS Frntotemporal dementia burden of care
researchProduct

Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS

2010

Summary Using exome sequencing, we identified a p.R191Q amino acid change in the valosin-containing protein ( VCP ) gene in an Italian family with autosomal dominantly inherited amyotrophic lateral sclerosis (ALS). Mutations in VCP have previously been identified in families with Inclusion Body Myopathy, Paget disease, and Frontotemporal Dementia (IBMPFD). Screening of VCP in a cohort of 210 familial ALS cases and 78 autopsy-proven ALS cases identified four additional mutations including a p.R155H mutation in a pathologically proven case of ALS. VCP protein is essential for maturation of ubiquitin-containing autophagosomes, and mutant VCP toxicity is partially mediated through its effect on…

Adenosine TriphosphataseMaleCell Cycle ProteinsUBQLN2Cohort Studies0302 clinical medicineReference ValuesValosin Containing ProteinCell Cycle ProteinReference ValueAmyotrophic lateral sclerosisExome sequencingAdenosine TriphosphatasesGenetics0303 health sciencesGeneral NeuroscienceExonsMiddle AgedPedigree3. Good healthMultisystem proteinopathyFemaleSettore MED/26 - NeurologiaCase-Control StudieChromosomes Human Pair 9HumanFrontotemporal dementiaNeuroscience(all)Valosin-containing proteinExonBiologyProtein degradationTARDBPArticle03 medical and health sciencesmedicineHumansAged030304 developmental biologyAmyotrophic lateral sclerosis familial ALS exome sequencingNeuroscience (all)business.industryAmyotrophic Lateral Sclerosismedicine.diseaseAmino Acid SubstitutionCase-Control StudiesMutationbiology.proteinCohort Studiebusiness030217 neurology & neurosurgeryAmyotrophic Lateral SclerosiNeuron
researchProduct

Pure Progressive Amnesia and the APPV717G Mutation

2009

We report an isolated, slowly progressive, pure amnestic phenotype in a 59-year-old member of a family affected by autosomal dominant familial Alzheimer disease. Early-onset Alzheimer disease in this family was associated with a V717G mutation in the amyloid precursor protein gene (APP). Subjective impairment of episodic memory began in our subject at the age of 44 years and subsequent, longitudinal neuropsychologic assessment confirmed progressive, severe, global impairment of memory functions over a period of 14 years with preservation of other cognitive domains. The mean annual hippocampal atrophy rate, determined by volumetric magnetic resonance imaging was intermediate between values p…

AdultMaleAgingPathologymedicine.medical_specialtyGlycineAmnesiaHippocampusAmyloid beta-Protein PrecursorAtrophyAlzheimer DiseasemedicineHumansDementiaMemory disorderEpisodic memoryAgedSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaCognitive disorderValineMiddle Agedmedicine.diseaseAPPV717G mutation.PedigreePsychiatry and Mental healthClinical PsychologyPhenotypeMutationDisease ProgressionPure progressive amnesiaFemaleAmnesiaAtrophyGeriatrics and Gerontologymedicine.symptomAlzheimer's diseasePsychologyGerontologyFrontotemporal dementia
researchProduct

Taking both sides: do unilateral anterior temporal lobe lesions disrupt semantic memory?

2010

The most selective disorder of central conceptual knowledge arises in semantic dementia, a degenerative condition associated with bilateral atrophy of the inferior and polar regions of the temporal lobes. Likewise, semantic impairment in both herpes simplex virus encephalitis and Alzheimer's disease is typically associated with bilateral, anterior temporal pathology. These findings suggest that conceptual representations are supported via an interconnected, bilateral, anterior temporal network and that it may take damage to both sides to produce an unequivocal deficit of central semantic memory. We tested and supported this hypothesis by investigating a case series of 20 patients with unila…

AdultMaleDatabases Factualunilateral anterior temporal lobe lesions semantic memorymedicine.medical_treatmentSemantic dementiaNeuropsychological TestsTemporal lobeYoung AdultEpilepsyMemorymedicineHumansSemantic memoryCognitive neuropsychologyAgedMemory DisordersSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaCognitionMiddle Agedmedicine.diseaseTemporal LobeFunctional imagingTranscranial magnetic stimulationFemaleNeurology (clinical)AtrophyPsychologyNeuroscience
researchProduct

Does angioedema influence the quality of life in patients with chronic spontaneous urticaria?

2019

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAdolescentmedia_common.quotation_subjectImmunologyMEDLINEEmbarrassmentSleep Initiation and Maintenance DisordersmedicineHumansImmunology and AllergyChronic UrticariaIn patientAngioedemaEmbarrassmentmedia_commonAngioedemabusiness.industryPruritusMiddle AgedMental Status and Dementia TestsDermatologyQuality of LifeFemalePolandmedicine.symptombusinessStress PsychologicalAnnals of Allergy Asthma & Immunology
researchProduct

Moral reasoning and moral conflict in patients of the amyotrophic lateral sclerosis – Frontotemporal dementia spectrum

2020

The aim of this study was to investigate the moral reasoning and moral conflict in patients of the amyotrophic lateral sclerosis – frontotemporal dementia (ALSFTD) spectrum. Ten ALS patients without cognitive impairment, 10 ALS patients with cognitive or behavioral impairment, 10 ALSFTD patients and 23 controls were examined with neuropsychological and behavioral tests as well as with a set of eight well -designed moral dilemmas. The responses to the moral dilemmas were used as proxies to evaluate interpersonal moral reasoning. Reactivity to change, reaction time and arousal were used as markers of moral conflict. ALSFTD patients showed more “utilitarian” responses and less moral conflict t…

AdultMaleSocial PsychologyDecision MakingMoral reasoningDevelopmentNeuropsychological TestsMoralsfrontotemporal dementia050105 experimental psychologyConflict Psychological03 medical and health sciencesBehavioral NeuroscienceDisability EvaluationMoral conflict0302 clinical medicineMental ProcessesmedicineReaction TimeHumans0501 psychology and cognitive sciencesIn patientAmyotrophic lateral sclerosishealth care economics and organizationsAgedPsychiatric Status Rating Scalesmoral reasoning05 social sciencesmoral conflictMiddle Agedmedicine.diseaseAmyotrophic lateral sclerosishumanitiesMoral reasoningFemalePsychologyCognition Disorders030217 neurology & neurosurgeryFrontotemporal dementiaFrontotemporal dementiaClinical psychologySocial Neuroscience
researchProduct

Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients.

2003

Experimental and clinical studies give evidence for breakdown of membrane phospholipids during neurodegeneration. In the present study, we measured the levels of glycerophosphocholine (GPCh), phosphocholine (PCh), and choline, that is, water-soluble metabolites of phosphatidylcholine (PtdCho), in human cerebrospinal fluid (CSF). Among 30 cognitively normal patients the average CSF levels of GPCh, phosphocholine and choline were 3.64, 1.28, and 1.93 microM, respectively; metabolite levels did not change with increasing age. When compared with age-matched controls, patients with Alzheimer's disease had elevated levels of all choline metabolites: GPCh was significantly increased by 76% (P<0.01…

AdultMalemedicine.medical_specialtyAgingAdolescentMetabolitePhosphorylcholineCholinechemistry.chemical_compoundPhospholipase A2Cerebrospinal fluidAlzheimer DiseasePhosphatidylcholineInternal medicinemedicineCholineHumansVascular dementiaPhosphocholineAgedAged 80 and overbiologyPhosphorylcholineGeneral NeuroscienceDementia VascularAge FactorsMiddle Agedmedicine.diseaseGlycerylphosphorylcholineEndocrinologychemistryImmunologybiology.proteinFemaleNeurology (clinical)Geriatrics and GerontologyBiomarkersDevelopmental BiologyNeurobiology of aging
researchProduct

Cerebral Microbleeds and Long-Term Cognitive Outcome: Longitudinal Cohort Study of Stroke Clinic Patients

2012

&lt;i&gt;Background:&lt;/i&gt; Vascular cognitive impairment causes significant disability in the elderly and is common following ischaemic stroke. Although the underlying mechanisms and prognostic factors remain unclear, small vessel diseases are known to contribute. Cerebral microbleeds (CMBs) are a magnetic resonance imaging (MRI) manifestation of small vessel diseases and may contribute to vascular cognitive impairment, particularly frontal-executive functions. We hypothesized that baseline CMBs would predict long-term cognitive outcome, specifically frontal-executive function. &lt;i&gt;Methods:&lt;/i&gt; A cohort of consecutive patients found to have CMBs when first referred to a strok…

AdultMalemedicine.medical_specialtyNeuropsychological TestsCohort StudiesExecutive FunctionCognitionInternal medicinemedicineHumansLongitudinal StudiesNeuropsychological assessmentCognitive declineVascular dementiaStrokeAgedCerebral HemorrhageAged 80 and overIntelligence TestsSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicamedicine.diagnostic_testbusiness.industryMagnetic resonance imagingCognitionCerebral InfarctionMiddle Agedmedicine.diseaseMagnetic Resonance ImagingStrokeNeurologymicrobleedsCohortPhysical therapyFemaleNeurology (clinical)Verbal memoryCognition DisordersCardiology and Cardiovascular MedicinebusinessPsychomotor PerformanceFollow-Up StudiesCerebrovascular Diseases
researchProduct

The Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-an…

2022

The COVID-19 pandemic may have a disproportionate impact on people with dementia/mild cognitive impairment (MCI) due to isolation and loss of services. The aim of this systematic review was to investigate the effects of the COVID-19 lockdown on neuropsychiatric symptoms (NPS) in people living with dementia/MCI. Two authors searched major electronic databases from inception to June 2021 for observational studies investigating COVID-19 and NPS in people with dementia/MCI. Summary estimates of mean differences in NPS scores pre- versus post-COVID-19 were calculated using a random-effects model, weighting cases using inverse variance. Study quality and risk of bias were assessed by the Newcastl…

Aged 80 and overMalemild cognitive impairment neuropsychiatric symptomsCognitive Dysfunction/diagnosisDementia/psychologyCOVID-19Neuropsychological TestsPsychiatry and Mental healthmental disordersCommunicable Disease ControlCOVID-19 dementia mild cognitive impairment neuropsychiatric symptomsHumansCognitive DysfunctionDementiaFemaleGeriatrics and GerontologyGerontologyPandemicsCOVID-19/epidemiologydementiaAgedPsychogeriatrics : the official journal of the Japanese Psychogeriatric Society
researchProduct

Prevalence and features of delirium in older patients admitted to rehabilitation facilities

2022

Background: Delirium is thought to be common across various settings of care; however, still little research has been conducted in rehabilitation. Aim: We investigated the prevalence of delirium, its features and motor subtypes in older patients admitted to rehabilitation facilities during the three editions of the “Delirium Day project”. Methods: We conducted a cross-sectional study in which 1237 older patients (age ≥ 65 years old) admitted to 50 Italian rehabilitation wards during the three editions of the “Delirium Day project” (2015 to 2017) were included. Delirium was evaluated through the 4AT and its motor subtype with the Delirium Motor Subtype Scale. Results: Delirium was detected i…

AgingDisabilityRehabilitationDeliriumDelirium; Dementia; Disability; Physical restraint; RehabilitationCross-Sectional StudiesActivities of Daily Livingmental disordersPrevalenceHumansDementiaPhysical restraintGeriatrics and GerontologyAgedAging Clinical and Experimental Research
researchProduct